Transepithelial Transport of the Bioactive Tripeptide, Val-Pro-Pro, in Human Intestinal Caco-2 Cell Monolayers.

  • SATAKE Makoto
    <i>Department of Applied Biological Chemistry, The University of Tokyo</i>
  • ENJOH Masashi
    <i>Department of Applied Biological Chemistry, The University of Tokyo</i>
  • NAKAMURA Yasunori
    <i>Research and Development Center, The Calpis Co. Ltd.</i>
  • TAKANO Toshiaki
    <i>Research and Development Center, The Calpis Co. Ltd.</i>
  • KAWAMURA Yukio
    <i>Department of Applied Life Science, Kinki University</i>
  • ARAI Soichi
    <i>Department of Applied Biological Chemistry, The University of Tokyo</i>
  • SHIMIZU Makoto
    <i>Department of Applied Biological Chemistry, The University of Tokyo</i>

この論文をさがす

抄録

  Some of the food-derived tripeptides with angiotensin converting enzyme (ACE)-inhibitory activity have been reported to be hypotensive after being orally administered. The mechanism for the intestinal transport of these tripeptides was studied by using monolayer- cultured human intestinal Caco-2 cells which express many enterocyte-like functions including the peptide transporter(PepT1)-mediated transport system. Val-Pro-Pro, an ACE-inhibitory peptide from fermented milk, was used as a model tripeptide. A significant amount of intact Val-Pro-Pro was transported across the Caco-2 cell monolayer. This transport was hardly inhibited by a competitive substrate for PepT1. Since no intact Val-Pro-Pro was detected in the cells, Val-Pro-Pro apically taken by Caco-2 cells via PepT1 was likely to have been quickly hydrolyzed by intracellular peptidases, producing free Val and Pro. These findings suggest that PepT1-mediated transport was not involved in the transepithelial transport of intact Val-Pro-Pro. Paracellular diffusion is suggested to have been the main mechanism for the transport of intact Val-Pro-Pro across the Caco-2 cell monolayer.<br>

収録刊行物

被引用文献 (12)*注記

もっと見る

参考文献 (40)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ